Gene: ZNF558
Official Full Name: zinc finger protein 558provided by HGNC
Gene Summary: Predicted to enable DNA-binding transcription factor activity, RNA polymerase II-specific and RNA polymerase II transcription regulatory region sequence-specific DNA binding activity. Predicted to be involved in regulation of transcription by RNA polymerase II. Predicted to be active in nucleus. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO23508 | ZNF558 Knockout cell line (HeLa) | Human | ZNF558 | 1:3~1:6 | Negative | Online Inquiry |
KO23509 | ZNF558 Knockout cell line (HCT 116) | Human | ZNF558 | 1:2~1:4 | Negative | Online Inquiry |
KO23510 | ZNF558 Knockout cell line (A549) | Human | ZNF558 | 1:3~1:4 | Negative | Online Inquiry |
ZNF558 Gene Knockout Cell Lines are genetically engineered cell lines specifically designed to facilitate the study of the ZNF558 gene, which encodes a zinc finger protein involved in various cellular processes. This innovative product exemplifies the precision of gene editing technology, utilizing CRISPR/Cas9 methodologies to create stable knockout models that allow researchers to elucidate the function of ZNF558 in biological systems.
The key function of these cell lines lies in the targeted disruption of the ZNF558 gene, permitting in-depth analysis of its role in gene regulation, cellular differentiation, and potential implications in disease pathology. By studying ZNF558 knockout cells, researchers can observe alterations in downstream signaling pathways and gene expression, thereby gaining valuable insights into the gene's contribution to normal physiology and its involvement in conditions such as cancer or neurodegenerative diseases.
The scientific importance of ZNF558 Gene Knockout Cell Lines is underscored by their applicability in both fundamental research and translational medicine. These models allow for the exploration of gene function in a controlled environment, providing robust platforms for drug screening, functional genomics, and the identification of novel therapeutic targets.
One of the standout advantages of these knockout cell lines is their flexibility and ease of use compared to other gene-editing alternatives, such as siRNA or overexpression systems. Unlike transient methods, ZNF558 knockout cell lines establish a stable genetic modification, which enhances reproducibility in experiments and reduces variability in results. Moreover, their compatibility with various assays makes them a versatile tool in the investigator’s toolkit.
For researchers and clinicians looking to deepen their understanding of ZNF558 and its biological significance, investing in ZNF558 Gene Knockout Cell Lines presents an exceptional opportunity. These cell lines not only afford the tools needed to investigate critical biological questions, but they also open avenues for innovative discoveries that could translate into meaningful clinical advancements.
Our company has extensive expertise in the development of cutting-edge genetic models, ensuring that our product offerings meet the highest standards of quality and reliability. By choosing our ZNF558 Gene Knockout Cell Lines, you align your research with a trusted provider committed to enhancing scientific exploration and discovery.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.